S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Biden's State of the Union to tout policy wins on economy
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
'Knock at the Cabin' knocks off 'Avatar' at the box office
Ally Financial expands NASCAR spend with 2 new partnerships
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Biden's State of the Union to tout policy wins on economy
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
'Knock at the Cabin' knocks off 'Avatar' at the box office
Ally Financial expands NASCAR spend with 2 new partnerships
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Biden's State of the Union to tout policy wins on economy
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
'Knock at the Cabin' knocks off 'Avatar' at the box office
Ally Financial expands NASCAR spend with 2 new partnerships
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Biden's State of the Union to tout policy wins on economy
How will EU ban and West's price cap on Russian diesel work?
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Evacuations urged in Ohio town as train wreck smolders
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
'Knock at the Cabin' knocks off 'Avatar' at the box office
Ally Financial expands NASCAR spend with 2 new partnerships
OTCMKTS:BIEI

Premier Biomedical - BIEI Stock Forecast, Price & News

$0.0047
0.00 (0.00%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.0041
▼
$0.0050
50-Day Range
N/A
52-Week Range
$0.0011
▼
$0.0069
Volume
12.43 million shs
Average Volume
14.80 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BIEI stock logo

About Premier Biomedical (OTCMKTS:BIEI) Stock

Premier Biomedical, Inc. is a research-based company, which engages in the development and discovery of medical products. It focuses on the development and distribution of hemp oil based topical pain relief products. The company was founded by Mitchell S. Felder on May 10, 2010 and is headquartered in Southfield, MI.

Receive BIEI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Premier Biomedical and its competitors with MarketBeat's FREE daily newsletter.

BIEI Stock News Headlines

February 1, 2023 | finance.yahoo.com
Nova Graphene Ballistics (OTC PINK: BIEI) Retains Award Winning Communication Firm To Expand Public Messaging
January 19, 2023 | finance.yahoo.com
Premier Biomedical Inc. (OTC PINK: BIEI), now known as Nova Graphene Ballistics, Inc., Releases its Graphene Ballistic Plate Production Approach
February 5, 2023 | Investor Place Media (Ad)
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
December 20, 2022 | finance.yahoo.com
Premier Biomedical Inc. (OTC PINK: BIEI), now known as Nova-Graphene Ballistics, Inc., Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology
December 14, 2022 | benzinga.com
Premier Biomedical Stock (OTC:BIEI), Earnings Estimates, EPS, and Revenue
August 12, 2022 | apnews.com
BIOMEDevice Boston Brings Back “Master Class Start-Up Series” in Partnership with MassMEDIC
August 8, 2022 | ca.finance.yahoo.com
Premier Biomedical, Inc. (BIEI)
May 17, 2022 | apnews.com
BioIVT to Provide Rare Biosamples for the FNIH Biomarkers Consortium Neurodegenerative Disease Project
February 5, 2023 | Investor Place Media (Ad)
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
October 26, 2021 | finance.yahoo.com
Premier Biomedical Appoints Dr. Patricio Reyes to Board and Chief Technical Officer
November 15, 2020 | nasdaq.com
BIEI After-Hours Quotes
August 9, 2020 | barrons.com
Premier Biomedical Inc.
June 17, 2020 | www.bloomberg.com
Premier Biomedical Inc., CEO William Hartman Visits Uptick Newswire’s “Stock Day” with Everett Jolly
June 5, 2020 | www.finanznachrichten.de
Halberd Corporation: Halberd Corp. Announces Correction/Clarification to Eliminate Name Confusion
June 5, 2020 | finance.yahoo.com
Halberd Corp. Announces Correction/Clarification to Eliminate Name Confusion
May 12, 2020 | finance.yahoo.com
Premier Biomedical, Technology Health, and Datatecnics Agree to Collaborate on Extracorporeal "Map and Zap(TM)" Coronavirus Treatment
May 5, 2020 | www.finanznachrichten.de
Premier Biomedical, Inc.: Premier Biomedical Rescinds Previously Planned Increase in Authorized Shares
May 5, 2020 | finance.yahoo.com
Premier Biomedical Rescinds Previously Planned Increase in Authorized Shares
April 14, 2020 | finance.yahoo.com
Premier Biomedical, Inc. Announces Second Covid-19 Treatment Provisional Patent Application Filed to Supplement Two Issued Patents
April 8, 2020 | finance.yahoo.com
Premier Biomedical, Halberd and Gold River Agree to Work Jointly to Develop Premier's Patented Extracorporeal Technology on COVID-19 Treatment And Proprietary Anti-Addiction Patch(TM)
April 6, 2020 | finance.yahoo.com
Premier Biomedical Realigns Business to Eliminate Convertible Debt, Cancel Reverse Split & Fund Covid-19 R&D
March 23, 2020 | finance.yahoo.com
Covid-19 Treatment Provisional Patent Application Filed; Premier Biomedical, Inc. Granted Global Commercial Rights
November 14, 2019 | www.finanznachrichten.de
Premier Biomedical, Inc.: Premier Biomedical Announces Evolution of Business Focus and Name Change
November 14, 2019 | finance.yahoo.com
Premier Biomedical Announces Evolution of Business Focus and Name Change
November 1, 2019 | markets.ft.com
Premier Biomedical Inc
October 21, 2019 | finance.yahoo.com
Premier Biomedical, Inc. CEO, William Hartman, Addresses Current Challenges with The Stock Day Podcast
September 19, 2019 | www.finanznachrichten.de
Premier Biomedical, Inc. Joins The Stock Day Podcast to Announce The Release of Its Anti-Addiction Patch
See More Headlines
Receive BIEI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Premier Biomedical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BIEI
CUSIP
N/A
CIK
1515740
Web
www.premierbiomedical.com
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • David Caplan
    Chairmen
  • John Maddox
    Chief Executive Officer & President
  • Carl Eller
    Vice President-Marketing & Planning
  • Brain A. Lebrecht
    Securities Counsel

Key Competitors

View All Competitors













BIEI Stock - Frequently Asked Questions

How have BIEI shares performed in 2023?

Premier Biomedical's stock was trading at $0.0044 on January 1st, 2023. Since then, BIEI shares have increased by 6.8% and is now trading at $0.0047.
View the best growth stocks for 2023 here.

Are investors shorting Premier Biomedical?

Premier Biomedical saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 88,600 shares, an increase of 65.0% from the December 31st total of 53,700 shares. Based on an average daily volume of 19,650,200 shares, the days-to-cover ratio is presently 0.0 days.
View Premier Biomedical's Short Interest.

What other stocks do shareholders of Premier Biomedical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Premier Biomedical investors own include Co-Diagnostics (CODX), Allena Pharmaceuticals (ALNA), CytoDyn (CYDY), Inovio Pharmaceuticals (INO), Sierra Oncology (SRRA), Vaxart (VXRT), MEI Pharma (MEIP), Novavax (NVAX), Rigel Pharmaceuticals (RIGL) and Selecta Biosciences (SELB).

What is Premier Biomedical's stock symbol?

Premier Biomedical trades on the OTCMKTS under the ticker symbol "BIEI."

How do I buy shares of Premier Biomedical?

Shares of BIEI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Premier Biomedical's stock price today?

One share of BIEI stock can currently be purchased for approximately $0.00.

This page (OTCMKTS:BIEI) was last updated on 2/5/2023 by MarketBeat.com Staff